Prescribing in patients with diabetes

This article, published in the New Zealand Journal of Primary Healthcare, sought to undertake a review of the literature about the impact of nurse prescribing on the delivery of healthcare services...

Hyperinsulinaemia

The idea of type 2 diabetes (T2D) being a progressive illness is almost redundant, with increasing evidence even confirming how T2D remission is possible. For example, Cucuzzella et al (2023: 146)...

Tackling diabetes the iDEAL way

Insights for Diabetes Excellence, Access and Learning (iDEAL) is a community interest company that is not for profit, and designed to work with local communities to share and promote best practice....

Using insulin to manage type 2 diabetes

The pharmacological pathway in the NICE guidelines on T2DM (NG28) is metformin as first line, or a choice of sulfonylurea (SU), pioglitazone, DPP-4 inhibitor, or SGLT-2 inhibitor if metformin not...

Avoiding and managing the side effects of type 2 diabetes treatments

When considering a treatment to improve glycaemic control, it is important to involve the individual in the decision-making process and to consider their specific circumstances and potential...

Insulin for diabetes: 100 years of therapy

During the summer of 1921, an unlikely team consisting of Frederick Banting, a newly established physician specialising in orthopaedics and a professor of physiology, and Charles Best, one of his lab...

Diabetes remission and diet data

Diabetes can stem from obesity, with increasing numbers of studies showing remission of diabetes through a reduction in body weight (Quimby et al, 2021). Further research looks at how different food...

Changing the way type 2 diabetes is managed

The main complications of diabetes are microvascular disease affecting the eyes, nerves and kidneys, and macrovascular disease leading to cardiovascular disease (CVD), cerebrovascular disease and...

Evidence-based use of newer agents in type 2 diabetes

Recent accumulating evidence on the use of newer therapies in type 2 diabetes (T2DM) is helping to define their position in treatment. This information coupled with the increasing priority given...

Diabetes care: a time to review prescribing approaches and reach out to local communities

There has been a bidirectional relationship between COVID-19 and diabetes, with increased rates of new diagnosis and an increased risk of severe COVID-19 for those already diagnosed (Rubino et al,...

Managing diabetes care in the COVID-19 pandemic

This piece of original research, carried out in May 2020 in China, used a questionnaire method to gather information about diabetic patients as a measure to determine recruitment before conducting a...

Reversible diabetes